-
In an effort to improve preparedness, the U.S. federal government is seeking to bolster Clinical Studies Network service capabilities for advanced clinical development of medical countermeasures to treat the adverse health effects resulting from exposure [Read more] -
Back by popular demand… the Sunday weekly wrap-up of our team picks for best reads in biodefense and health security. Send us your interesting reads by emailing editor@globalbiodefense.com or via Twitter @GlobalBioD POLICY + PRACTICES [Read more] -
Paramedics bury a man who died of the Nipah virus in Kozhikode, southern India, in May 2018. There is no vaccine for the virus, which can cause raging fevers, convulsions and vomiting, and kills up [Read more] -
The U.S. Centers for Disease Control and Prevention (CDC) said in a statement today that five Egyptian rousette fruit bats caught in Sierra Leone tested positive for the Marburg virus, a deadly hemorrhagic fever similar [Read more] -
Doubts are growing about whether the world’s emergency stockpile of 300,000 Ebola vaccine doses is enough to control future epidemics. Supply of the Merck shot, which is currently being used to fight a large and [Read more] -
The Walter Reed Army Institute of Research (WRAIR) is seeking sources that can provide the synthesis and delivery of mRNA products in different quantities and different sequences as needed by Malaria Vaccine Branch (MVB). MVB will [Read more] -
The Department of Homeland Security Office of Procurement Operations is conducting market research on technologies that can provide a comprehensive, cost effective solution to BioWatch’s current laboratory information management system. This desired sample tracking platform [Read more]
